The bond market has entered a financial twilight zone, and at this point, there doesn't seem to be a smooth way out.Market Insiderread more
"I think (rate cuts) will help, but whether they're going to be sufficient to counter the negative trade pressures and global growth slowdown and impact is debatable," one...Central Banksread more
China has used both monetary and fiscal measures to lift economic activity as its trade war with the U.S. looks set to intensify in the coming months.China Economyread more
Alibaba held a board meeting before its latest quarterly earnings release last week, during which the board decided to postpone the Hong Kong listing, Reuters reported.Technologyread more
President Donald Trump said on Twitter he was postponing a scheduled meeting with Denmark's prime minister because of her lack of interest in discussing a possible sale of...World Politicsread more
The two countries want to smash the civil aerospace duopoly enjoyed by Airbus and Boeing.Aerospace & Defenseread more
Federal Reserve Chairman Jerome Powell is set to deliver his annual speech on Friday at the Jackson Hole, Wyoming symposium, where he's expected to provide more clarity on the...Asia Marketsread more
After Elon Musk touts Tesla solar on Twitter, Walmart sues the electric vehicle and clean energy company over store rooftop panels that ignited.Technologyread more
U.S. and Asian investors poured $3.7 billion into U.K. tech start-ups in the first seven months of 2019, research shows.Technologyread more
Trump said he has "been thinking about payroll taxes for a long time" — and he cautioned that "whether or not we do something now, it's not being done because of recession."Politicsread more
Secretary of State Mike Pompeo privately told business executives and free traders that the trade war could end by the 2020 election and that hurdles to an immediate agreement...2020 Electionsread more
Jim Cramer has spent a lot of time recently discussing health care stocks, specifically the cost containment plays, because he thinks they are in the perfect sweet spot for the current market.
When he refers to controlling health care costs, he is referring to those companies that can use their scale to negotiate reduced prices with drugmakers and hospitals. Sometimes, in order to get a better understanding of a theme, it requires going off the tape to highlight privately held companies that are pioneering the way.
That is why Cramer spoke with Doctor on Demand, a service that allows patients to video conference with their doctors through the Web. This platform could ultimately lead to cheaper medical care and more convenience.
The company's service is currently available to both individuals in exchange for a flat fee, or businesses can provide it as a benefit to their employees. And now the competition in the online medical space has grown; Walgreens announced on Wednesday that it plans to expand its telemedicine business into 25 states by the end of the year.
Additionally the largest company in the industry, Teladoc, filed a week and a half ago to come public. All told, Cramer believes that the concept of telemedicine is both a game changer and investible.
Can Doctor on Demand continue to lead the way to changing the health-care landscape? To find out, Cramer spoke with Doctor on Demand's co-founder and CEO, Adam Jackson.
The first concern to most patients using Doctor on Demand is how to ensure that they are seeing both the right doctor and good doctor. Jackson explained that the application allows patients to browse a list of physicians and see where they went to school. The company's promise is to only employ board certified, American- trained medical doctors.
The CEO says Doctor on Demand is also helping to reduce the cost of medical care, as it offers a significantly cheaper option than going to an urgent care center or emergency room. Here's how it works: patients only pay $40 per visit: $30 goes to the doctor, and $10 goes to the company.
"First of all, if you just heard about us on TV or in the app store, you're going to use us because we're the only ones that go direct to consumers. Even if you don't have insurance, it doesn't matter. Put your credit card in for $40 you can see a doctor," Jackson said.
Because the company only makes $10 on each visit, it needs to maintain moderate to high volume, the CEO noted.
Read more from Mad Money with Jim Cramer
Cramer Remix: Banks rallying—here's my favorite
Cramer: Get ready—S&P approaching key levels
Cramer: Get out of this group, now
Cramer asked if Doctor on Demand could also have the potential to partner with pharmaceutical companies to provide assistance to patients, just as a company like Actavis does currently. Jackson stated that the company does not intend on going down that route, as they do not want to put any pressure on physicians or provider staff to prescribe medications.
"We'd rather have patients come to us because their insurance plan, their employer, or someone else they trust told them about it to get an honest and unbiased medical opinion," Jackson said.